stockportfolio.pro
Stocks / BGB vs HQL
BGB vs HQL
Blackstone Strategic Credit 2027 Term Fund and Abrdn Life Sciences Investors side by side — fundamentals from SEC filings, refreshed nightly. Sector: Financial Services.
| Blackstone Strategic Credit 2027 Term Fund (BGB) | Abrdn Life Sciences Investors (HQL) | |
|---|---|---|
| Market cap | $0.5B | $0.5B |
| Revenue (latest FY) | $35.84M | $86.39M |
| Net income (latest FY) | $30.08M | $85.59M |
| Revenue growth (5y CAGR) | — | — |
| Net margin | 83.9% | 99.1% |
| Return on equity | 5.4% | 16.7% |
| P/E ratio | 16.8 | 2.5 |
| Dividend yield | 8.6% | 12.4% |
| Profitable years (of last 10) | 3 | 3 |
| Positive free cash flow | — | — |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BGB — free Open HQL — freeFrequently asked questions
Which is bigger, BGB or HQL?
Abrdn Life Sciences Investors is larger by market capitalization — $0.5B versus $0.5B.
Which grows faster, BGB or HQL?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.